$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015
[Lowest Price Guaranteed: $2,500]

Published by Global Data: 25 Nov 2015 | 17586 | In Stock
Related Topics: Clinical Trials

Introduction

Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015" provides an overview of Hyperphosphatemia In Chronic Kidney Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperphosphatemia In Chronic Kidney Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 17

    Clinical Trials in G7 Countries by Trial Status 18

    Clinical Trials by E7 Countries: Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials 19

    Clinical Trials by Phase in E7 Countries 21

    Clinical Trials in E7 Countries by Trial Status 22

    Clinical Trials by Phase 23

    In Progress Trials by Phase 24

    Clinical Trials by Trial Status 25

    Clinical Trials by End Point Status 26

    Subjects Recruited Over a Period of Time 27

    Clinical Trials by Sponsor Type 28

    Prominent Sponsors 29

    Top Companies Participating in Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials 30

    Prominent Drugs 32

    Clinical Trial Profile Snapshots 33

    Appendix 81

    Abbreviations 81

    Definitions 81

    Research Methodology 82

    Secondary Research 82

    About GlobalData 83

    Contact Us 83

    Disclaimer 83

    Source 84

List Of Tables
in Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015

List of Tables

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Region, 2015* 6

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials, G7 Countries (%), 2015* 16

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18

Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials, E7 Countries (%), 2015* 20

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 23

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 24

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

List Of Figures, Charts and Diagrams
in Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015

List of Figures

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials, G7 Countries (%), 2015* 15

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18

Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials, E7 Countries (%), 2015* 19

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 23

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 24

Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 82

Additional Details

Publisher

Global Data

Publisher Information

Reference

17586 | GDHC2993CTIDB

Number of Pages

84

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
ASIA PACIFIC HYPERPHOSPHATEMIA DRUG MARKET FORECAST 2017-2025
KEY FINDINGSThe Asia-Pacific hyperphosphatemia drugs market is worth 8 million in 2017. The marke...
24 Jun 2017 by Inkwood Research USD $1,250 More Info
EUROPE HYPERPHOSPHATEMIA DRUG MARKET FORECAST 207-2025
KEY FINDINGSThe Europe hyperphosphatemia drug market is expected to grow at a CAGR of 15.38% during ...
24 Jun 2017 by Inkwood Research USD $1,250 More Info
NORTH AMERICA HYPERPHOSPHATEMIA DRUG MARKET FORECAST 2017-2025
KEY FINDINGSThe North America hyperphosphatemia drug market is expected to grow at a CAGR of 14.76%....
24 Jun 2017 by Inkwood Research USD $1,250 More Info
GLOBAL HYPERPHOSPHATEMIA DRUG MARKET FORECAST 2017-2025
KEY FINDINGSThe global hyperphosphatemia drugs market is expected to grow at a CAGR of 15.95 % durin...
24 Jun 2017 by Inkwood Research USD $2,500 More Info
Hyperphosphatemia-Pipeline Insights, 2017
DelveInsight’s, “ Hyperphosphatemia-Pipeline Insights, 2017”, report provides in depth insights on t...
30 May 2017 by Delve Insight USD $1,250 More Info
Hyperphosphatemia In Chronic Kidney Disease-Pipeline Insights, 2017
DelveInsight’s, “ Hyperphosphatemia In Chronic Kidney Disease-Pipeline Insights, 2017”, report provi...
30 May 2017 by Delve Insight USD $1,250 More Info
Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2016
Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2016SummaryGlobal Markets Direct's...
30 Dec 2016 by Global Markets Direct USD $2,000 More Info
Hyperphosphatemia Global Clinical Trials Review, H2, 2016
Hyperphosphatemia Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, ...
27 Dec 2016 by Global Data USD $2,500 More Info
Global Hyperphosphatemia Drugs Market Insights, Opportunities, Analysis, Market Shares and Forecast 2016 – 2022
Hypophosphatemia predicted in patients who have an antiquity of starvation, anorexia/bulimia, alcoho...
01 Jan 2016 by Occams Business Research USD $5,900 More Info
Global Hyperphosphatemia Drugs Market Insights, Opportunities, Analysis, Market Shares and Forecast 2016 – 2022
Hypophosphatemia predicted in patients who have an antiquity of starvation, anorexia/bulimia, alcoho...
01 Jan 1970 by Occams Business Research USD $3,900 More Info

This report is published by Global Data

Download Free Report Summary PDF

Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...